All Products

GHK-Cu 50 mg

Copper-Binding Tripeptide (Gly-His-Lys Complex)

Lab Tested

Substance: GHK-Cu (Copper Peptide)
Strength: 50 mg/vial
Form: Lyophilized powder
Packaging: 2 mL glass vial
Manufacturer: Dragon Pharma, Europe

Authentic Dragon Pharma Product

Free Shipping on Orders $800+

Discreet Packaging Guaranteed

$27.00 $45.00

Warehouse :

International

U.S. Domestic

You will save $18.00

Dragon Pharma GHK-Cu 50 mg

GHK-Cu 50 mg delivers a potent research-grade dose of the remarkable copper-binding tripeptide (Gly-His-Lys) complexed with copper ions. Originally discovered as a human plasma peptide that declines with age, GHK-Cu has emerged as a multifaceted research compound with profound effects on tissue repair, collagen synthesis, and cellular communication. The peptide's unique structure allows it to chelate copper (Cu²⁺), creating a bioactive complex that interacts with multiple biological pathways. GHK-Cu functions as a master regulator of gene expression, influencing over 4,000 human genes—approximately one-third of the human genome—shifting gene activity from a diseased, aged state toward a healthier, more youthful pattern of expression.

For bodybuilders, athletes, and longevity researchers in the USA, Dragon Pharma GHK-Cu 50 mg offers a comprehensive research tool that bridges cosmetic, therapeutic, and performance applications. Intense training creates micro-tears in connective tissues, increases oxidative stress, and accelerates skin aging through repeated stretching and cortisol exposure. Research into GHK-Cu focuses on its potential to accelerate recovery at the cellular level by enhancing collagen and elastin production, reducing inflammation, promoting angiogenesis (new blood vessel formation), and protecting against oxidative damage. Beyond skin and connective tissue, it also demonstrates neuroprotective, anti-cancer, and systemic anti-aging properties in preclinical models. Manufactured by Dragon Pharma under strict quality control, this 50 mg vial of lyophilized powder represents one of the highest concentrations available for research, enabling extensive studies on tissue engineering, wound healing, and age-related degeneration.

Key Benefits:

Potent Collagen & Elastin Synthesis: Upregulates genes responsible for collagen I, III, IV, and elastin production, fundamental for skin, tendon, and ligament repair research.
Systemic Anti-Inflammatory Action: Reduces key inflammatory cytokines (TNF-α, IL-6) while increasing anti-inflammatory molecules, creating an optimal healing environment.
Angiogenesis & Tissue Regeneration: Promotes formation of new blood vessels and attracts repair cells (fibroblasts, endothelial cells) to injury sites.
Antioxidant & DNA Protection: Copper complex provides antioxidant activity while the peptide helps repair DNA damage and protect against radiation/oxidative stress.
High-Concentration Research Formula: 50 mg per vial provides substantial material for topical, subcutaneous, and systemic research protocols across multiple applications.

Each 2 mL vial contains 50 mg of high-purity GHK-Cu peptide complex (Gly-His-Lys tripeptide bound to copper ions) as a distinctive blue lyophilized powder, synthesized and purified under Dragon Pharma's pharmaceutical-grade quality standards.

Product Specifications

Product Name	GHK-Cu 50 mg
Manufacturer	Dragon Pharma
Substance	GHK-Cu (Copper Peptide Complex)
Packaging	2 mL glass vial, lyophilized blue powder
Lab Test Result	55.10 mg (110.2% of label claim) - November 2025 batch
Half-Life	Approximately 2 hours (but epigenetic effects are cumulative)
Recommended Cycle	Research cycles vary: 30-90 days for skin/tissue studies, longer for systemic anti-aging research (3-6 months).
Form	Lyophilized (freeze-dried) powder for reconstitution
Aromatization	Not applicable (non-hormonal peptide complex)
Dosage (Research Models)	Studied with various protocols: daily subcutaneous, topical application, or intermittent systemic administration.

Usage Guidelines

Research Application Only: This information summarizes scientific literature for educational context. Dragon Pharma GHK-Cu 50 mg is a research chemical for laboratory investigation, not for human consumption.

In experimental settings, GHK-Cu is reconstituted with bacteriostatic water. The distinctive blue color confirms successful copper binding. Research administration routes include subcutaneous (for systemic effects), topical (for skin/wound studies), and sometimes intramuscular near injury sites. Due to its gene-regulatory effects, research benefits are cumulative over weeks to months. Studies often combine administration routes—for example, systemic plus topical for skin research. The peptide is generally well-tolerated in animal models, but high concentrations in topical research can cause temporary itching due to histamine release (a normal part of the healing cascade).

Skin & Connective Tissue Research (30-90 days): Daily administration (often topical ± subcutaneous) to study collagen synthesis, wound healing, and scar reduction in animal models.
Systemic Anti-Aging & Recovery Protocol (3-6 months): Longer-term subcutaneous administration to investigate effects on gene expression, inflammation, and tissue repair throughout the body.

Post Cycle Therapy (PCT):

GHK-Cu does not affect the HPTA, so traditional PCT with SERMs like Clomid is not applicable. However, as a gene-regulatory peptide, its effects may persist after cessation. Research protocols typically don't require specific "off" compounds but may focus on maintaining results with supportive agents like BPC-157 for continued tissue repair or lower-dose GHK-Cu for maintenance in long-term studies.

Synergistic Research Combinations:

GHK-Cu is frequently studied alongside other regenerative compounds. For comprehensive tissue repair research, it pairs exceptionally well with TB-500 (Thymosin Beta-4) for enhanced cell migration and healing. In skin rejuvenation studies, combining with AOD 9604 may target fat and skin elasticity synergistically. For athletes, researching alongside Ipamorelin could enhance GH-mediated recovery. In systemic anti-aging models, Epitalon may complement its telomere and epigenetic effects.

Third-Party Lab Tested

Dragon Pharma GHK-Cu 50 mg Lab Test Result November 2025

2025-11-10

View Result

55.10 mg

Lab Analysis Note: The November 2025 third-party HPLC test confirms 55.10 mg of GHK-Cu peptide complex per vial—110.2% of the labeled 50 mg. This significant overfill demonstrates Dragon Pharma's commitment to delivering premium research products. The distinctive blue color indicates proper copper binding, and mass spectrometry verifies the correct Gly-His-Lys sequence with copper coordination.

Storage Instructions

Proper storage is crucial to maintain the stability of this copper-peptide complex.

Unreconstituted Powder: Store the sealed vial in a freezer at -20°C (-4°F) or colder for long-term stability. The lyophilized blue powder remains stable for up to 36 months under these conditions. Protect from light (the blue color can fade with UV exposure) and moisture.
After Reconstitution: Once reconstituted with bacteriostatic water, the blue solution must be refrigerated immediately at 2°C to 8°C (36°F to 46°F). The reconstituted solution is typically stable for research use for 4-6 weeks when refrigerated and protected from light. For best results, use within 30 days. Do not freeze the liquid solution.
Special Note on Color: The blue color is normal and indicates proper copper binding. Some fading may occur over time in solution but doesn't necessarily indicate loss of potency if stored properly. Always use sterile technique to prevent bacterial growth in the copper-rich solution.

What does GHK-Cu peptide do?

GHK-Cu is a research copper peptide complex that influences over 4,000 genes, shifting expression toward a healthier, younger pattern. Key research effects include stimulating collagen and elastin synthesis, reducing inflammation, promoting wound healing and angiogenesis (new blood vessels), protecting against oxidative stress and DNA damage, and supporting tissue regeneration in skin, tendons, and other connective tissues.

How much GHK-Cu should I inject?

Research Disclaimer: GHK-Cu is for laboratory research only. In preclinical studies, dosage varies by research goal. For systemic effects in animal models, studies might use 1-2 mg/kg body weight daily or every other day. For topical wound/skin research, concentrations of 1-10% in creams or gels are common. The 50 mg vial from Dragon Pharma provides ample material for various research protocols, including dose-response studies.

What are the side effects of GHK-Cu peptides?

In research models, GHK-Cu is generally well-tolerated. The most commonly noted effect in topical studies is temporary itching or mild irritation at the application site, which is actually a normal histamine response that initiates healing. Systemic administration in animals shows excellent safety profiles. The copper is tightly bound and doesn't cause copper toxicity at research doses. No hormonal or serious adverse effects are reported in the literature.

How long does it take for GHK-Cu to work?

Research timelines vary: Initial gene expression changes occur within hours. For wound healing, effects may be visible in days. For collagen synthesis and skin improvement in animal models, measurable changes typically appear after 4-8 weeks of consistent use. Systemic anti-aging and tissue regeneration effects are studied over 3-6 month periods. Benefits are cumulative due to its gene-regulatory mechanism.

Why is Dragon Pharma GHK-Cu 50 mg blue?

The distinctive blue color is a hallmark of quality, indicating successful copper binding to the Gly-His-Lys tripeptide. The blue comes from the d-d electronic transitions in the copper(II) coordination complex. This color confirms the product is properly synthesized as GHK-Cu, not just the peptide alone. Faded or absent blue color would suggest improper copper binding or degradation. Dragon Pharma's vibrant blue powder demonstrates correct synthesis and high purity.

No customer reviews yet.